The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Jan. 22, 2015
Applicant:

Alnylam Pharmaceuticals, Inc., Cambridge, MA (US);

Inventors:

Muthiah Manoharan, Cambridge, MA (US);

Kallanthottathil G. Rajeev, Cambridge, MA (US);

Alexander V. Kelin, Cambridge, MA (US);

Sudhakar Rao Takkellapati, Cambridge, MA (US);

Shigeo Matsuda, Cambridge, MA (US);

Assignee:

ALNYLAM PHARMACEUTICALS, INC., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C07H 21/04 (2006.01); C07H 21/00 (2006.01); C07H 19/04 (2006.01); C07H 19/10 (2006.01); C07H 19/20 (2006.01); C07H 19/048 (2006.01); C07H 19/167 (2006.01); C07H 19/073 (2006.01); C07H 19/173 (2006.01);
U.S. Cl.
CPC ...
C07H 21/02 (2013.01); C07H 19/073 (2013.01); C07H 19/10 (2013.01); C07H 19/173 (2013.01); C07H 19/20 (2013.01); C07H 21/00 (2013.01);
Abstract

The present invention provides nucleosides of formula (1) and oligonucleotides comprising at least one nucleoside of formula (2): Another aspect of the invention relates to a method of inhibiting the expression of a gene in cell, the method comprising (a) contacting an oligonucleotide of the invention with the cell; and (b) maintaining the cell from step (a) for a time sufficient to obtain degradation of the mRNA of the target gene.


Find Patent Forward Citations

Loading…